231 related articles for article (PubMed ID: 37355516)
1. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.
Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H
Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516
[TBL] [Abstract][Full Text] [Related]
2. lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression.
Yang T; Li Y; Wang G; Guo L; Sun F; Li S; Deng X; Liu J
Biomed Res Int; 2022; 2022():3858249. PubMed ID: 35993042
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
[TBL] [Abstract][Full Text] [Related]
4. The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a.
Kong Q; Liang C; Jin Y; Pan Y; Tong D; Kong Q; Zhou J
Cell Mol Biol Lett; 2019; 24():26. PubMed ID: 30988676
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis.
Shen MY; Zhou GR; -Y Zhang Z
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1771-1777. PubMed ID: 32141545
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling.
Qian H; Chen L; Huang J; Wang X; Ma S; Cui F; Luo L; Ling L; Luo K; Zheng G
J Mol Med (Berl); 2018 Aug; 96(8):753-764. PubMed ID: 29872866
[TBL] [Abstract][Full Text] [Related]
7. lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.
Zhu K; Miao C; Tian Y; Qin Z; Xue J; Xia J; Zhu S; Xu A; Yang J; Wang Z
J Cell Mol Med; 2020 Sep; 24(17):10013-10026. PubMed ID: 33460239
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2'-O methylation.
Zhu Y; Xiao B; Liu M; Chen M; Xia N; Guo H; Huang J; Liu Z; Wang F
Cell Mol Biol Lett; 2023 Oct; 28(1):89. PubMed ID: 37891494
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MIR4435-2HG-mediated upregulation of TGF-β1 promotes migration and proliferation of nonsmall cell lung cancer cells.
Yang M; He X; Huang X; Wang J; He Y; Wei L
Environ Toxicol; 2020 May; 35(5):582-590. PubMed ID: 31875359
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling.
Wang H; Wu M; Lu Y; He K; Cai X; Yu X; Lu J; Teng L
Aging (Albany NY); 2019 Sep; 11(17):6657-6673. PubMed ID: 31484163
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.
Gao LF; Li W; Liu YG; Zhang C; Gao WN; Wang L
Front Oncol; 2021; 11():661288. PubMed ID: 34532282
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of lncRNA TINCR is associated with high-grade, invasive, and recurring tumors, and facilitates proliferation in vitro and in vivo of urothelial carcinoma of the bladder.
Han Y; Sun G
Urol Oncol; 2020 Sep; 38(9):738.e1-738.e8. PubMed ID: 32622721
[TBL] [Abstract][Full Text] [Related]
13. MIR4435-2HG, miR-125b-5p, and Sema4D axis affects the aggressiveness of colorectal cancer cells.
Yu M; Yi Z; Chen S; Chen X; Xie X
Folia Histochem Cytobiol; 2022; 60(2):191-202. PubMed ID: 35730423
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils.
Yu H; Chen C; Han F; Tang J; Deng M; Niu Y; Lai M; Zhang H
Cancer Immunol Res; 2022 Sep; 10(9):1095-1110. PubMed ID: 35862232
[TBL] [Abstract][Full Text] [Related]
15. Identification of Long Non-Coding RNA MIR4435-2HG as a Prognostic Biomarker in Bladder Cancer.
Hu Z; Ma S; Sun Y; Long G; Chen K
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011373
[TBL] [Abstract][Full Text] [Related]
16. MIR4435-2HG regulates cancer cell behaviors in oral squamous cell carcinoma cell growth by upregulating TGF-β1.
Shen H; Sun B; Yang Y; Cai X; Bi L; Deng L; Zhang L
Odontology; 2020 Oct; 108(4):553-559. PubMed ID: 32016787
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p/YWHAZ axis.
Shen X; Ding Y; Lu F; Yuan H; Luan W
Am J Transl Res; 2020; 12(10):6381-6394. PubMed ID: 33194037
[TBL] [Abstract][Full Text] [Related]
18. PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition.
Chen X; Chen RX; Wei WS; Li YH; Feng ZH; Tan L; Chen JW; Yuan GJ; Chen SL; Guo SJ; Xiao KH; Liu ZW; Luo JH; Zhou FJ; Xie D
Clin Cancer Res; 2018 Dec; 24(24):6319-6330. PubMed ID: 30305293
[TBL] [Abstract][Full Text] [Related]
19. M2 Macrophage-Derived Exosomal lncRNA MIR4435-2HG Promotes Progression of Infantile Hemangiomas by Targeting HNRNPA1.
Li Z; Cao Z; Li N; Wang L; Fu C; Huo R; Xu G; Tian C; Bi J
Int J Nanomedicine; 2023; 18():5943-5960. PubMed ID: 37881607
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.
Ke J; Wang Q; Zhang W; Ni S; Mei H
Am J Transl Res; 2022; 14(8):5441-5454. PubMed ID: 36105009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
